/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a definitive...
Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases
Provides scaled entry into mechanical thrombectomy and neurovascular, key strategic adjacencies
Conference call at 8:00 ... [18135 chars]